Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction

Background: Higher levels of thyroid autoantibodies in follicular fluid (FF) of thyroid autoimmunity (TAI) positive women are strongly correlated with serum levels and may have effect on the post-implantation embryo development. Literature highlights that levothyroxine (LT4) treatment may attenuate...

Full description

Bibliographic Details
Main Authors: Medenica Sanja, Garalejić Eliana, Abazović Džihan, Bukumirić Zoran, Paschou Stavroula A., Arsić Biljana, Vujošević Snežana, Međo Biljana, Žarković Miloš
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2023-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582301027M.pdf
_version_ 1828048837837586432
author Medenica Sanja
Garalejić Eliana
Abazović Džihan
Bukumirić Zoran
Paschou Stavroula A.
Arsić Biljana
Vujošević Snežana
Međo Biljana
Žarković Miloš
author_facet Medenica Sanja
Garalejić Eliana
Abazović Džihan
Bukumirić Zoran
Paschou Stavroula A.
Arsić Biljana
Vujošević Snežana
Međo Biljana
Žarković Miloš
author_sort Medenica Sanja
collection DOAJ
description Background: Higher levels of thyroid autoantibodies in follicular fluid (FF) of thyroid autoimmunity (TAI) positive women are strongly correlated with serum levels and may have effect on the post-implantation embryo development. Literature highlights that levothyroxine (LT4) treatment may attenuate the risk of adverse pregnancy outcomes. The aim of the study was to estimate the pregnancy and newborn outcomes in women with FF thyroid autoantibodies undergoing assisted reproductive technology (A RT). Methods: The study population included 24 women with confirmed clinical pregnancy, 8 TAI positive and 16 TAI negative women. LT4 supplementation was applied in 20.8% patients, TAI positive. Results: Pregnancy outcomes were: twin pregnancy rate 4 1 .7 % , early miscarriage rate 8.3% , late miscarriage rate 4.2% , preterm birth rate 16.7% , term birth rate 70.8% , live birth rate 96.0% . There was significant difference in serum and in FF TgAbs (p< 0.001)betw een the groups according to TAI, while serum fT 3 was lower in the group with TAI (p = 0 .0 4 7 ). Serum P 4 was higher in LT4 treated group (p = 0 .0 0 5 ), with TAI, and newborns in this group had higher birth weight (p = 0.001) and height (p = 0 .0 0 8 ). Maternal complications occurred in 23.8% of patients. No congenital malformations in newborns were noted. Conclusions: Thyroid autoantibodies present in FF may have an effect on the post-implantation embryo development, but have no effect on further course of pregnancy. The special benefit of LT4 treatment for successful A R T outcome was demonstrated for newborn anthropometric parameters.
first_indexed 2024-04-10T19:01:53Z
format Article
id doaj.art-0507e28dc1ba4064ba8730fb7e31592c
institution Directory Open Access Journal
issn 1452-8258
1452-8266
language English
last_indexed 2024-04-10T19:01:53Z
publishDate 2023-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj.art-0507e28dc1ba4064ba8730fb7e31592c2023-01-31T08:14:07ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662023-01-01421273310.5937/jomb0-352431452-82582301027MPregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproductionMedenica Sanja0Garalejić Eliana1Abazović Džihan2Bukumirić Zoran3https://orcid.org/0000-0002-7609-4504Paschou Stavroula A.4Arsić Biljana5Vujošević Snežana6Međo Biljana7Žarković Miloš8University of Montenegro, School of Medicine, Clinical Center of Montenegro, Internal Medicine Clinic, Department of Endocrinology, Podgorica, MontenegroClinic for Gynecology and Obstetrics "Narodni front", In Vitro Fertilisation Department, Belgrade, SerbiaEmergency Medicine Center of Montenegro, Podgorica, Montenegro University of Belgrade, Institute for Medical Statistics and Informatics, Faculty of Medicine, Belgrade, SerbiaNational and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital, Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Athens, GreeceClinic for Gynecology and Obstetrics "Narodni front", In Vitro Fertilisation Department, Belgrade, SerbiaUniversity of Montenegro, School of Medicine, Clinical Center of Montenegro, Internal Medicine Clinic, Department of Endocrinology, Podgorica, MontenegroUniversity of Belgrade, School of Medicine, Belgrade, SerbiaUniversity of Belgrade, School of Medicine, Belgrade, SerbiaBackground: Higher levels of thyroid autoantibodies in follicular fluid (FF) of thyroid autoimmunity (TAI) positive women are strongly correlated with serum levels and may have effect on the post-implantation embryo development. Literature highlights that levothyroxine (LT4) treatment may attenuate the risk of adverse pregnancy outcomes. The aim of the study was to estimate the pregnancy and newborn outcomes in women with FF thyroid autoantibodies undergoing assisted reproductive technology (A RT). Methods: The study population included 24 women with confirmed clinical pregnancy, 8 TAI positive and 16 TAI negative women. LT4 supplementation was applied in 20.8% patients, TAI positive. Results: Pregnancy outcomes were: twin pregnancy rate 4 1 .7 % , early miscarriage rate 8.3% , late miscarriage rate 4.2% , preterm birth rate 16.7% , term birth rate 70.8% , live birth rate 96.0% . There was significant difference in serum and in FF TgAbs (p< 0.001)betw een the groups according to TAI, while serum fT 3 was lower in the group with TAI (p = 0 .0 4 7 ). Serum P 4 was higher in LT4 treated group (p = 0 .0 0 5 ), with TAI, and newborns in this group had higher birth weight (p = 0.001) and height (p = 0 .0 0 8 ). Maternal complications occurred in 23.8% of patients. No congenital malformations in newborns were noted. Conclusions: Thyroid autoantibodies present in FF may have an effect on the post-implantation embryo development, but have no effect on further course of pregnancy. The special benefit of LT4 treatment for successful A R T outcome was demonstrated for newborn anthropometric parameters.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582301027M.pdfassisted reproductive technologyfollicular fluidpregnancythyroid autoimmunity
spellingShingle Medenica Sanja
Garalejić Eliana
Abazović Džihan
Bukumirić Zoran
Paschou Stavroula A.
Arsić Biljana
Vujošević Snežana
Međo Biljana
Žarković Miloš
Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
Journal of Medical Biochemistry
assisted reproductive technology
follicular fluid
pregnancy
thyroid autoimmunity
title Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
title_full Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
title_fullStr Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
title_full_unstemmed Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
title_short Pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
title_sort pregnancy outcomes and newborn characteristics in women with follicular fluid thyroid autoantibodies undergoing assisted reproduction
topic assisted reproductive technology
follicular fluid
pregnancy
thyroid autoimmunity
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582301027M.pdf
work_keys_str_mv AT medenicasanja pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT garalejiceliana pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT abazovicdzihan pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT bukumiriczoran pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT paschoustavroulaa pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT arsicbiljana pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT vujosevicsnezana pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT međobiljana pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction
AT zarkovicmilos pregnancyoutcomesandnewborncharacteristicsinwomenwithfollicularfluidthyroidautoantibodiesundergoingassistedreproduction